ICMR ready to transfer technology for commercialisation of TB detection kit
- July 25, 2024
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
ICMR ready to transfer technology for commercialisation of TB detection kit
Subject: Science and Tech
Sec: Health
Context:
- Indian Council of Medical Research (ICMR) has begun work on bringing in affordable, faster and easy-to-use testing technology for detection of tuberculosis (TB).The Council has invited Expressions of Interest (EOI) from organisations, companies, and manufacturers for undertaking ‘Transfer of Technology’ for the commercialisation of A CRISPR Cas based TB detection system for the detection of Mycobacterium TB.
More on News:
- Developed by ICMR- RMRCNE Institute, Dibrugarh the technology is touted as the “world’s cheapest TB testing system”.
- The system can detect the TB bacteria using DNA from a patient’s saliva for a very low cost, can identify the bacteria with preliminary symptoms, and test over 1,500 samples simultaneously within approximately two hours.ICMR-RMRCNE Institute would accelerate the development of the product and its commercialization.
- ICMR would provide technical support through its team of experienced scientists in study planning, product development, development of study protocol, results/data analysis, outcome assessment, safety & efficacy assessment, product improvement, etc.
Tuberculosis:
- Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis.
- Affect any organ of the body.
- The most common ones are the lungs, pleura (lining around the lungs), lymph nodes, intestines, spine, and brain.
- Transmission:
- It is an airborne infection that spreads through close contact with the infected, especially in densely populated spaces with poor ventilation.
- Symptoms:
- Cough with sputum
- Blood at times
- Chest pains
- Weakness
- Weight loss
- Fever
- Night sweats.
- Treatment:
- Standard 6-month course of 4 antimicrobial drugs that are provided with information, supervision and support to the patient by a health worker or trained volunteer.
- Anti-TB medicines have been used for decades and strains that are resistant to 1 or more of the medicines have been documented in every country surveyed.
- Multidrug-resistant Tuberculosis (MDR-TB) is a form of TB caused by bacteria that do not respond to isoniazid and rifampicin, the 2 most powerful, first-line anti-TB drugs.
- MDR-TB is treatable and curable by using second-line drugs such as bedaquiline.
- Extensively drug-resistant TB (XDR-TB) is a more serious form of MDR-TB caused by bacteria that do not respond to the most effective second-line anti-TB drugs, often leaving patients without any further treatment options.
- Multidrug-resistant Tuberculosis (MDR-TB) is a form of TB caused by bacteria that do not respond to isoniazid and rifampicin, the 2 most powerful, first-line anti-TB drugs.
- Drugs for TB:
- Isoniazid (INH): This drug is a cornerstone of TB treatment and is highly effective against Mycobacterium tuberculosis.
- It works by inhibiting the synthesis of mycolic acids in the bacterial cell wall.
- Rifampicin (RIF): Works by inhibiting the synthesis of RNA in the bacteria.
- It is often used in combination with other drugs to treat TB and is crucial for preventing the development of drug resistance.
- Delamanid: Newer drug that is used in the treatment of multidrug-resistant TB (MDR-TB) and is often used in combination with other drugs.
- Isoniazid (INH): This drug is a cornerstone of TB treatment and is highly effective against Mycobacterium tuberculosis.
CRISPR Technology:
- About:
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a gene editing technology, which replicates natural defence mechanism in bacteria to fight virus attacks, using a special protein called Cas9.
- It usually involves the introduction of a new gene, or suppression of an existing gene, through a process described as genetic engineering.
- CRISPR technology does not involve the introduction of any new gene from the outside.
- CRISPR-Cas9 technology is often described as ‘Genetic Scissors’.
- Its mechanism is often compared to the ‘cut-copy-paste’, or ‘find-replace’ functionalities in common computer programmes.
- A bad stretch in the DNA sequence, which is the cause of disease or disorder, is located, cut, and removed and then replaced with a ‘correct’ sequence.
- The tools used to achieve this are biochemical i.e., specific protein and RNA molecules.
- The technology replicates a natural defence mechanism in some bacteria that uses a similar method to protect itself from virus attacks.
- Mechanism:
- The first task is to identify the particular sequence of genes that is the cause of the trouble.
- Once that is done, an RNA molecule is programmed to locate this sequence on the DNA strand, just like the ‘find’ or ‘search’ function on a computer.
- After this Cas9 is used to break the DNA strand at specific points, and remove the bad sequence.
- A DNA strand, when broken, has a natural tendency to re-attach and heal itself. But if the auto-repair mechanism is allowed to continue, the bad sequence can regrow.
- So, scientists intervene during the auto-repair process by supplying the correct sequence of genetic codes, which attaches to the broken DNA strand.
- It is like cutting out the damaged part of a long zipper, and replacing it with a normally functioning part.
- So, scientists intervene during the auto-repair process by supplying the correct sequence of genetic codes, which attaches to the broken DNA strand.
- The entire process is programmable, and has remarkable efficiency, though the chances of error are not entirely ruled out.